Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 3658798, 12 pages
http://dx.doi.org/10.1155/2016/3658798
Research Article

Comparison of the Biological Characteristics of Mesenchymal Stem Cells Derived from Bone Marrow and Skin

1Institute of Dermatology, Taiyuan City Centre Hospital, Shanxi Provincial Key Laboratory of Immunological Skin Diseases, No. 1 Dong San Dao Xiang, Taiyuan, Shanxi 030009, China
2Department of Dermatology, Zibo City First Hospital, Shandong 255200, China

Received 13 January 2016; Revised 18 March 2016; Accepted 6 April 2016

Academic Editor: Shinn-Zong Lin

Copyright © 2016 Ruifeng Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. J. Friedenstein, R. K. Chailakhyan, and U. V. Gerasimov, “Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers,” Cell and Tissue Kinetics, vol. 20, no. 3, pp. 263–272, 1987. View at Google Scholar · View at Scopus
  2. M. Di Nicola, C. Carlo-Stella, M. Magni et al., “Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli,” Blood, vol. 99, no. 10, pp. 3838–3843, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Batten, P. Sarathchandra, J. W. Antoniw et al., “Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves,” Tissue Engineering, vol. 12, no. 8, pp. 2263–2273, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Gieseke, J. Böhringer, R. Bussolari, M. Dominici, R. Handgretinger, and I. Müller, “Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells,” Blood, vol. 116, no. 19, pp. 3770–3779, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Nemeth, A. Keane-Myers, J. M. Brown et al., “Bone marrow stromal cells use TGF-β to suppress allergic responses in a mouse model of ragweed-induced asthma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 12, pp. 5652–5657, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. J. Cutler, V. Limbani, J. Girdlestone, and C. V. Navarrete, “Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation,” The Journal of Immunology, vol. 185, no. 11, pp. 6617–6623, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Miao, J. Jin, L. Chen et al., “Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells,” Cell Biology International, vol. 30, no. 9, pp. 681–687, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. W.-C. Son, J.-W. Yun, and B.-H. Kim, “Adipose-derived mesenchymal stem cells reduce MMP-1 expression in UV-irradiated human dermal fibroblasts: therapeutic potential in skin wrinkling,” Bioscience, Biotechnology and Biochemistry, vol. 79, no. 6, pp. 919–925, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Vaculik, C. Schuster, W. Bauer et al., “Human dermis harbors distinct mesenchymal stromal cell subsets,” Journal of Investigative Dermatology, vol. 132, no. 3, part 1, pp. 563–574, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Campanati, M. Orciani, S. Gorbi, F. Regoli, R. Di Primio, and A. Offidani, “Effect of biologic therapies targeting tumour necrosis factor-α on cutaneous mesenchymal stem cells in psoriasis,” British Journal of Dermatology, vol. 167, no. 1, pp. 68–76, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Orciani, S. Gorbi, M. Benedetti et al., “Oxidative stress defense in human-skin-derived mesenchymal stem cells versus human keratinocytes: different mechanisms of protection and cell selection,” Free Radical Biology and Medicine, vol. 49, no. 5, pp. 830–838, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Zhang, R. Liu, G. Yin, X. Li, J. Li, and J. Zhang, “Differential cytokine secretion of cultured bone marrow stromal cells from patients with psoriasis and healthy volunteers,” European Journal of Dermatology, vol. 20, no. 1, pp. 49–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Hou, R. Liu, X. Niu et al., “Biological characteristics and gene expression pattern of bone marrow mesenchymal stem cells in patients with psoriasis,” Experimental Dermatology, vol. 23, no. 7, pp. 521–523, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Hou, G. Yin, P. An et al., “DNA methylation of dermal MSCs in psoriasis: identification of epigenetically dysregulated genes,” Journal of Dermatological Science, vol. 72, no. 2, pp. 103–109, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Liu, Y. Yang, X. Yan, and K. Zhang, “Abnormalities in cytokine secretion from mesenchymal stem cells in psoriatic skin lesions,” European Journal of Dermatology, vol. 23, no. 5, pp. 600–607, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Liu, Y. Wang, X. Zhao, Y. Yang, and K. Zhang, “Lymphocyte inhibition is compromised in mesenchymal stem cells from psoriatic skin,” European Journal of Dermatology, vol. 24, no. 5, pp. 560–567, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Haniffa, M. P. Collin, C. D. Buckley, and F. Dazzi, “Mesenchymal stem cells: the fibroblasts' new clothes?” Haematologica, vol. 94, no. 2, pp. 258–263, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Bogdan, N. Donhauser, R. Döring, M. Röllinghoff, A. Diefenbach, and M. G. Rittig, “Fibroblasts as host cells in latent leishmaniosis,” Journal of Experimental Medicine, vol. 191, no. 12, pp. 2121–2129, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Halfon, N. Abramov, B. Grinblat, and I. Ginis, “Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging,” Stem Cells and Development, vol. 20, no. 1, pp. 53–66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position Statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Chen, Y. Yu, L. Chen et al., “Human umbilical cord mesenchymal stem cells: a new therapeutic option for tooth regeneration,” Stem Cells International, vol. 2015, Article ID 549432, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Zhang, H. Yuan, H. Liu et al., “Well-aligned chitosan-based ultrafine fibers committed teno-lineage differentiation of human induced pluripotent stem cells for Achilles tendon regeneration,” Biomaterials, vol. 53, pp. 716–730, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Park, S. Park, S. Ryu et al., “Graphene-regulated cardiomyogenic differentiation process of mesenchymal stem cells by enhancing the expression of extracellular matrix proteins and cell signaling molecules,” Advanced Healthcare Materials, vol. 3, no. 2, pp. 176–181, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. Q. Liu, G. Cheng, Z. Wang, S. Zhan, B. Xiong, and X. Zhao, “Bone marrow-derived mesenchymal stem cells differentiate into nerve-like cells in vitro after transfection with brain-derived neurotrophic factor gene,” In Vitro Cellular & Developmental Biology—Animal, vol. 51, no. 3, pp. 319–327, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. G. M. Policastro, F. Lin, L. A. Smith Callahan et al., “OGP functionalized phenylalanine-based poly(ester urea) for enhancing osteoinductive potential of human mesenchymal stem cells,” Biomacromolecules, vol. 16, no. 4, pp. 1358–1371, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Talaei-Khozani, M. Borhani-Haghighi, M. Ayatollahi, and Z. Vojdani, “An in vitro model for hepatocyte-like cell differentiation from wharton's jelly derived-mesenchymal stem cells by cell-base aggregates,” Gastroenterology and Hepatology from Bed to Bench, vol. 8, no. 3, pp. 188–198, 2015. View at Google Scholar · View at Scopus
  27. K. Zhang, S. Yan, G. Li, L. Cui, and J. Yin, “In-situ birth of MSCs multicellular spheroids in poly (L-glutamic acid)/chitosan scaffold for hyaline-like cartilage regeneration,” Biomaterials, vol. 71, pp. 24–34, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Zhou, Y. Tao, C. Liang, Y. Zhang, H. Li, and Q. Chen, “BMP3 alone and together with TGF-β promote the differentiation of human mesenchymal stem cells into a nucleus pulposus-like phenotype,” International Journal of Molecular Sciences, vol. 16, no. 9, pp. 20344–20359, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. Y.-H. Chao, H.-P. Wu, K.-H. Wu et al., “An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis e110338,” PLoS ONE, vol. 9, no. 10, Article ID e110338, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. M. D. Nicola, C. Carlo-Stella, M. Magni et al., “Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli,” Blood, vol. 99, no. 10, pp. 3838–3843, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Uccelli, L. Moretta, and V. Pistoia, “Mesenchymal stem cells in health and disease,” Nature Reviews Immunology, vol. 8, no. 9, pp. 726–736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Nishiwaki, T. Nakayama, S. Saito et al., “Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis,” International Journal of Hematology, vol. 96, no. 3, pp. 295–300, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. X.-H. Li, C.-J. Gao, W.-M. Da et al., “Reduced intensity conditioning, combined transplantation of haploidentical hematopoietic stem cells and mesenchymal stem cells in patients with severe aplastic anemia,” PLoS ONE, vol. 9, no. 3, Article ID e89666, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. N. H. Nicolay, R. Lopez Perez, J. Debus, and P. E. Huber, “Mesenchymal stem cells—a new hope for radiotherapy-induced tissue damage?” Cancer Letters, vol. 366, no. 2, pp. 133–140, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Pipino, P. Di Tomo, D. Mandatori et al., “Calcium sensing receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: correlation with osteogenic differentiation,” Stem Cells and Development, vol. 23, no. 24, pp. 2959–2971, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. P. J. Kim, M. Mahmoudi, X. Ge et al., “Direct evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium,” Circulation Research, vol. 116, no. 7, pp. e40–e50, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Sonomoto, K. Yamaoka, and Y. Tanaka, “An approach to bone and cartilage repair of rheumatoid arthritis by mesenchymal stem cells,” Journal of UOEH, vol. 36, no. 2, pp. 141–146, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. Y.-L. Hu, B. Huang, T.-Y. Zhang et al., “Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection,” Molecular Pharmaceutics, vol. 9, no. 9, pp. 2698–2709, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Al-Nbaheen, R. vishnubalaji, D. Ali et al., “Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential,” Stem Cell Reviews and Reports, vol. 9, no. 1, pp. 32–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Mattioli-Belmonte, G. Teti, V. Salvatore et al., “Stem cell origin differently affects bone tissue engineering strategies,” Frontiers in Physiology, vol. 6, article 266, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Ferretti, G. Vozzi, M. Falconi et al., “Role of IGF1 and IGF1/VEGF on human mesenchymal stromal cells in bone healing: two sources and two fates,” Tissue Engineering, Part A, vol. 20, no. 17-18, pp. 2473–2482, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Vaculik, C. Schuster, W. Bauer et al., “Human dermis harbors distinct mesenchymal stromal cell subsets,” Journal of Investigative Dermatology, vol. 132, no. 3, pp. 563–574, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Foudah, M. Monfrini, E. Donzelli et al., “Expression of neural markers by undifferentiated mesenchymal-like stem cells from different sources,” Journal of Immunology Research, vol. 2014, Article ID 987678, 16 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus